GLIOZ 100

Glioz 100mg Capsule contains temozolomide as its active ingredient. This medication falls under the category of Antineoplastic agents. It is used to treat brain cancer, including glioblastoma multiforme in adults and malignant glioma, which encompasses glioblastoma multiforme or anaplastic astrocytoma in patients over three years of age. Glioblastoma and anaplastic astrocytoma are among the most prevalent and aggressive forms of brain cancer, associated with low survival rates.

Anaplastic astrocytoma is managed with Glioz 100mg Capsule or radiotherapy following a biopsy, while Glioblastoma multiforme is treated using a combination of radiotherapy and Glioz 100mg Capsule, which continues as maintenance therapy.

Common side effects linked to Glioz 100mg Capsule include nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, fatigue, frequent urination, vision and hearing issues, elevated blood sugar levels, muscle damage, pain in muscles and joints, memory impairment, coordination difficulties, infections, sleep disturbances, and weight loss. It is important to inform your doctor if any of these symptoms are bothersome or persist.

Notify your physician if you have an allergy to Glioz 100mg Capsule or any of its components. Prior to commencing treatment with this medication, inform your doctor if you have a hepatitis B infection, anemia, low platelet count, reduced levels of RBC and WBC, blood clotting disorders, or any liver or kidney issues. Your physician will regularly monitor your WBC and platelet levels. Avoid using this medication if you are pregnant or breastfeeding. Both men and women should employ birth control methods to prevent pregnancy and fathering a child.